Review article
Glucagon-like peptide 1 and cardiac cell survival
Péptido similar al glucagón tipo 1 y supervivencia de la célula cardiaca
Read
6045
Timeswas read the article
879
Total PDF
5166
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 28 | 6 | 34 |
| 2025 11 | 148 | 25 | 173 |
| 2025 10 | 72 | 14 | 86 |
| 2025 9 | 82 | 15 | 97 |
| 2025 8 | 63 | 11 | 74 |
| 2025 7 | 109 | 7 | 116 |
| 2025 6 | 62 | 4 | 66 |
| 2025 5 | 46 | 5 | 51 |
| 2025 4 | 77 | 8 | 85 |
| 2025 3 | 48 | 8 | 56 |
| 2025 2 | 29 | 5 | 34 |
| 2025 1 | 40 | 2 | 42 |
| 2024 12 | 28 | 5 | 33 |
| 2024 11 | 31 | 5 | 36 |
| 2024 10 | 15 | 6 | 21 |
| 2024 9 | 21 | 7 | 28 |
| 2024 8 | 27 | 2 | 29 |
| 2024 7 | 29 | 1 | 30 |
| 2024 6 | 20 | 2 | 22 |
| 2024 5 | 29 | 3 | 32 |
| 2024 4 | 25 | 2 | 27 |
| 2024 3 | 77 | 3 | 80 |
| 2024 2 | 49 | 4 | 53 |
| 2024 1 | 44 | 10 | 54 |
| 2023 12 | 58 | 5 | 63 |
| 2023 11 | 42 | 4 | 46 |
| 2023 10 | 48 | 7 | 55 |
| 2023 9 | 29 | 2 | 31 |
| 2023 8 | 15 | 3 | 18 |
| 2023 7 | 33 | 4 | 37 |
| 2023 6 | 39 | 8 | 47 |
| 2023 5 | 65 | 5 | 70 |
| 2023 4 | 58 | 1 | 59 |
| 2023 3 | 59 | 1 | 60 |
| 2023 2 | 29 | 3 | 32 |
| 2023 1 | 13 | 6 | 19 |
| 2022 12 | 39 | 6 | 45 |
| 2022 11 | 51 | 12 | 63 |
| 2022 10 | 22 | 8 | 30 |
| 2022 9 | 18 | 6 | 24 |
| 2022 8 | 29 | 7 | 36 |
| 2022 7 | 22 | 8 | 30 |
| 2022 6 | 22 | 8 | 30 |
| 2022 5 | 17 | 14 | 31 |
| 2022 4 | 15 | 11 | 26 |
| 2022 3 | 32 | 9 | 41 |
| 2022 2 | 15 | 3 | 18 |
| 2022 1 | 24 | 13 | 37 |
| 2021 12 | 33 | 8 | 41 |
| 2021 11 | 33 | 8 | 41 |
| 2021 10 | 44 | 8 | 52 |
| 2021 9 | 32 | 11 | 43 |
| 2021 8 | 24 | 9 | 33 |
| 2021 7 | 23 | 6 | 29 |
| 2021 6 | 17 | 4 | 21 |
| 2021 5 | 21 | 8 | 29 |
| 2021 4 | 45 | 11 | 56 |
| 2021 3 | 15 | 7 | 22 |
| 2021 2 | 21 | 5 | 26 |
| 2021 1 | 14 | 9 | 23 |
| 2020 12 | 18 | 7 | 25 |
| 2020 11 | 28 | 5 | 33 |
| 2020 10 | 15 | 5 | 20 |
| 2020 9 | 23 | 11 | 34 |
| 2020 8 | 24 | 4 | 28 |
| 2020 7 | 31 | 14 | 45 |
| 2020 6 | 37 | 4 | 41 |
| 2020 5 | 31 | 7 | 38 |
| 2020 4 | 24 | 2 | 26 |
| 2020 3 | 37 | 2 | 39 |
| 2020 2 | 26 | 2 | 28 |
| 2020 1 | 28 | 8 | 36 |
| 2019 12 | 68 | 10 | 78 |
| 2019 11 | 10 | 3 | 13 |
| 2019 10 | 11 | 1 | 12 |
| 2019 9 | 18 | 3 | 21 |
| 2019 8 | 48 | 7 | 55 |
| 2019 7 | 55 | 7 | 62 |
| 2019 6 | 42 | 8 | 50 |
| 2019 5 | 96 | 8 | 104 |
| 2019 4 | 77 | 3 | 80 |
| 2019 3 | 24 | 7 | 31 |
| 2019 2 | 38 | 1 | 39 |
| 2019 1 | 61 | 6 | 67 |
| 2018 12 | 34 | 3 | 37 |
| 2018 11 | 44 | 2 | 46 |
| 2018 10 | 54 | 7 | 61 |
| 2018 9 | 53 | 6 | 59 |
| 2018 8 | 56 | 0 | 56 |
| 2018 7 | 44 | 1 | 45 |
| 2018 6 | 33 | 1 | 34 |
| 2018 5 | 32 | 3 | 35 |
| 2018 4 | 16 | 1 | 17 |
| 2018 3 | 201 | 0 | 201 |
| 2018 2 | 26 | 1 | 27 |
| 2018 1 | 25 | 1 | 26 |
| 2017 12 | 17 | 1 | 18 |
| 2017 11 | 16 | 0 | 16 |
| 2017 10 | 29 | 1 | 30 |
| 2017 9 | 15 | 4 | 19 |
| 2017 8 | 39 | 3 | 42 |
| 2017 7 | 29 | 2 | 31 |
| 2017 6 | 86 | 13 | 99 |
| 2017 5 | 53 | 9 | 62 |
| 2017 4 | 39 | 4 | 43 |
| 2017 3 | 42 | 17 | 59 |
| 2017 2 | 68 | 6 | 74 |
| 2017 1 | 30 | 1 | 31 |
| 2016 12 | 39 | 5 | 44 |
| 2016 11 | 31 | 5 | 36 |
| 2016 10 | 54 | 4 | 58 |
| 2016 9 | 83 | 4 | 87 |
| 2016 8 | 31 | 7 | 38 |
| 2016 7 | 28 | 4 | 32 |
| 2016 6 | 24 | 7 | 31 |
| 2016 5 | 27 | 12 | 39 |
| 2016 4 | 24 | 13 | 37 |
| 2016 3 | 33 | 14 | 47 |
| 2016 2 | 30 | 15 | 45 |
| 2016 1 | 22 | 19 | 41 |
| 2015 12 | 22 | 11 | 33 |
| 2015 11 | 21 | 14 | 35 |
| 2015 10 | 29 | 16 | 45 |
| 2015 9 | 43 | 9 | 52 |
| 2015 8 | 54 | 7 | 61 |
| 2015 7 | 40 | 7 | 47 |
| 2015 6 | 20 | 0 | 20 |
| 2015 5 | 30 | 5 | 35 |
| 2015 4 | 27 | 14 | 41 |
| 2015 3 | 34 | 17 | 51 |
| 2015 2 | 18 | 14 | 32 |
| 2015 1 | 43 | 7 | 50 |
| 2014 12 | 53 | 10 | 63 |
| 2014 11 | 39 | 9 | 48 |
| 2014 5 | 1 | 0 | 1 |
Show all
